Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 56

1.

Targeting Glutamatergic Signaling and the PI3 Kinase Pathway to Halt Melanoma Progression.

Rosenberg SA, Niglio SA, Salehomoum N, Chan JL, Jeong BS, Wen Y, Li J, Fukui J, Chen S, Shin SS, Goydos JS.

Transl Oncol. 2015 Feb;8(1):1-9. doi: 10.1016/j.tranon.2014.11.001.

2.

Interdigitating dendritic cell sarcoma presenting in the skin: diagnosis and the role of surgical resection, chemotherapy and radiotherapy in management.

Rosenberg SA, Niglio SA, Jo VY, Goydos JS.

Rare Tumors. 2014 Dec 11;6(4):5573. doi: 10.4081/rt.2014.5573. eCollection 2014 Oct 27.

3.

Riluzole is a radio-sensitizing agent in an in vivo model of brain metastasis derived from GRM1 expressing human melanoma cells.

Wall BA, Yu LJ, Khan A, Haffty B, Goydos JS, Chen S.

Pigment Cell Melanoma Res. 2015 Jan;28(1):105-9. doi: 10.1111/pcmr.12327. Epub 2014 Nov 28.

PMID:
25363352
4.

Epac1 increases migration of endothelial cells and melanoma cells via FGF2-mediated paracrine signaling.

Baljinnyam E, Umemura M, Chuang C, De Lorenzo MS, Iwatsubo M, Chen S, Goydos JS, Ishikawa Y, Whitelock JM, Iwatsubo K.

Pigment Cell Melanoma Res. 2014 Jul;27(4):611-20. doi: 10.1111/pcmr.12250. Epub 2014 May 9.

5.

RUNX2 is overexpressed in melanoma cells and mediates their migration and invasion.

Boregowda RK, Olabisi OO, Abushahba W, Jeong BS, Haenssen KK, Chen W, Chekmareva M, Lasfar A, Foran DJ, Goydos JS, Cohen-Solal KA.

Cancer Lett. 2014 Jun 28;348(1-2):61-70. doi: 10.1016/j.canlet.2014.03.011. Epub 2014 Mar 18.

PMID:
24657655
6.

Store-operated Ca2+ entry (SOCE) regulates melanoma proliferation and cell migration.

Umemura M, Baljinnyam E, Feske S, De Lorenzo MS, Xie LH, Feng X, Oda K, Makino A, Fujita T, Yokoyama U, Iwatsubo M, Chen S, Goydos JS, Ishikawa Y, Iwatsubo K.

PLoS One. 2014 Feb 21;9(2):e89292. doi: 10.1371/journal.pone.0089292. eCollection 2014.

7.

Psychosocial correlates of sun protection behaviors among U.S. Hispanic adults.

Coups EJ, Stapleton JL, Manne SL, Hudson SV, Medina-Forrester A, Rosenberg SA, Gordon M, Tatum KS, Robinson JK, Natale-Pereira A, Goydos JS.

J Behav Med. 2014 Dec;37(6):1082-90. doi: 10.1007/s10865-014-9558-5. Epub 2014 Feb 15.

PMID:
24532153
8.

Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression.

Wen Y, Li J, Koo J, Shin SS, Lin Y, Jeong BS, Mehnert JM, Chen S, Cohen-Sola KA, Goydos JS.

Cancer Res. 2014 May 1;74(9):2499-509. doi: 10.1158/0008-5472.CAN-13-1531. Epub 2014 Feb 3.

9.

Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer.

Banda M, Speyer CL, Semma SN, Osuala KO, Kounalakis N, Torres Torres KE, Barnard NJ, Kim HJ, Sloane BF, Miller FR, Goydos JS, Gorski DH.

PLoS One. 2014 Jan 3;9(1):e81126. doi: 10.1371/journal.pone.0081126. eCollection 2014.

10.

Disruption of GRM1-mediated signalling using riluzole results in DNA damage in melanoma cells.

Wall BA, Wangari-Talbot J, Shin SS, Schiff D, Sierra J, Yu LJ, Khan A, Haffty B, Goydos JS, Chen S.

Pigment Cell Melanoma Res. 2014 Mar;27(2):263-74. doi: 10.1111/pcmr.12207. Epub 2014 Jan 22.

11.

Who should be offered a sentinel node biopsy for melanoma less than 1 mm in thickness?

Goydos JS.

J Clin Oncol. 2013 Dec 10;31(35):4385-6. doi: 10.1200/JCO.2013.51.8423. Epub 2013 Nov 4. No abstract available.

12.

Linguistic acculturation and skin cancer-related behaviors among Hispanics in the southern and western United States.

Coups EJ, Stapleton JL, Hudson SV, Medina-Forrester A, Rosenberg SA, Gordon MA, Natale-Pereira A, Goydos JS.

JAMA Dermatol. 2013 Jun;149(6):679-86. doi: 10.1001/jamadermatol.2013.745.

13.

Skin cancer surveillance behaviors among US Hispanic adults.

Coups EJ, Stapleton JL, Hudson SV, Medina-Forrester A, Rosenberg SA, Gordon M, Natale-Pereira A, Goydos JS.

J Am Acad Dermatol. 2013 Apr;68(4):576-84. doi: 10.1016/j.jaad.2012.09.032. Epub 2012 Nov 19.

14.

Sun protection and exposure behaviors among Hispanic adults in the United States: differences according to acculturation and among Hispanic subgroups.

Coups EJ, Stapleton JL, Hudson SV, Medina-Forrester A, Natale-Pereira A, Goydos JS.

BMC Public Health. 2012 Nov 15;12:985. doi: 10.1186/1471-2458-12-985.

15.

Non-canonical Smads phosphorylation induced by the glutamate release inhibitor, riluzole, through GSK3 activation in melanoma.

Abushahba W, Olabisi OO, Jeong BS, Boregowda RK, Wen Y, Liu F, Goydos JS, Lasfar A, Cohen-Solal KA.

PLoS One. 2012;7(10):e47312. doi: 10.1371/journal.pone.0047312. Epub 2012 Oct 12.

16.

Plant lectin can target receptors containing sialic acid, exemplified by podoplanin, to inhibit transformed cell growth and migration.

Ochoa-Alvarez JA, Krishnan H, Shen Y, Acharya NK, Han M, McNulty DE, Hasegawa H, Hyodo T, Senga T, Geng JG, Kosciuk M, Shin SS, Goydos JS, Temiakov D, Nagele RG, Goldberg GS.

PLoS One. 2012;7(7):e41845. doi: 10.1371/journal.pone.0041845. Epub 2012 Jul 23.

17.

Skin cancer screening among Hispanic adults in the United States: results from the 2010 National Health Interview Survey.

Coups EJ, Stapleton JL, Hudson SV, Medina-Forrester A, Goydos JS, Natale-Pereira A.

Arch Dermatol. 2012 Jul;148(7):861-3. doi: 10.1001/archdermatol.2012.615. No abstract available.

18.

Functional effects of GRM1 suppression in human melanoma cells.

Wangari-Talbot J, Wall BA, Goydos JS, Chen S.

Mol Cancer Res. 2012 Nov;10(11):1440-50. doi: 10.1158/1541-7786.MCR-12-0158. Epub 2012 Jul 13.

19.

Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapies.

Lee HJ, Wall BA, Wangari-Talbot J, Shin SS, Rosenberg S, Chan JL, Namkoong J, Goydos JS, Chen S.

Clin Cancer Res. 2011 Nov 15;17(22):7080-92. doi: 10.1158/1078-0432.CCR-11-0098. Epub 2011 Aug 15. Erratum in: Clin Cancer Res. 2012 Mar 1;18(5):1484.

20.

Gβγ subunits inhibit Epac-induced melanoma cell migration.

Baljinnyam E, Umemura M, De Lorenzo MS, Xie LH, Nowycky M, Iwatsubo M, Chen S, Goydos JS, Iwatsubo K.

BMC Cancer. 2011 Jun 17;11:256. doi: 10.1186/1471-2407-11-256.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk